Removal of Plasmodium falciparum-infected red blood cells from whole blood by leukoreduction filters

Transfusion

Volumn 49, Issue 2, 2009, Pages 337-346

  Cardo, Lisa J ^a,b   Salata, Jeanne ^a   Wilder, Donna ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM IONOPHORE; LIPOCORTIN 5; PHOSPHATIDYLSERINE;

ARTICLE; BLOOD FILTER; BLOOD FILTRATION; CELL MEMBRANE; CONTROLLED STUDY; DISEASE TRANSMISSION; ELECTRON MICROSCOPY; ERYTHROCYTE; ERYTHROCYTE ADHESIVENESS; ERYTHROCYTE TRANSFUSION; FLOW CYTOMETRY; HIGH EFFICIENCY LEUKOREDUCTION FILTER; HUMAN; HUMAN CELL; INFECTION; MALARIA; PLASMODIUM FALCIPARUM; PROTEIN EXPRESSION;

ANIMALS; ANNEXIN A5; ERYTHROCYTES; FILTRATION; FLOW CYTOMETRY; HUMANS; IONOPHORES; LEUKOCYTE REDUCTION PROCEDURES; MALARIA, FALCIPARUM; PARASITEMIA; PLASMODIUM FALCIPARUM;

EID: 58849139775     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.01974.x     Document Type: Article

References (43)

1. Visconti MR, Pennington J, Garner SF, Allain JP, Williamson LM. Assessment of removal of human cytomegalovirus from blood components by leukocyte depletion filters using real-time quantitative PCR. Blood 2004 103 : 1137 9.
2. Bowden RA, Slichter SJ, Sayers M, Weisdorf D, Cays M, Schoch G, Banaji M, Haake R, Welk K, Fisher L, McCullough J, Miller W. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995 86 : 3599 603.
3. Hillyer CD, Emmens RK, Zago-Novaretti M, Berkman EM. Methods for the reduction of transfusion-transmitted cytomegalovirus infection: filtration versus the use of seronegative donor units. Transfusion 1994 34 : 929 34.
4. Smith KL, Cobain T, Dunstan RA. Removal of cytomegalovirus DNA from donor blood by filtration. Br J Haematol 1993 83 : 640 2.
5. Kobayashi M, Yano M, Kwon KW, Takahashi TA, Ikeda H, Sekiguchi S. Leukocyte depletion of HTLV-I carrier red cell concentrates by filters. In : Sekiguchi S, editor. Clinical application of leucocyte depletion. Cambridge : Blackwell 1993. p. 138 48.
6. Mettille FC, Salata KF, Belanger KJ, Casleton BG, Kelly DJ. Reducing the risk of transfusion-transmitted rickettsial disease by WBC filtration, using Orentia tsutsugamushi in a model system. Transfusion 2000 40 : 290 6.
7. Moraes-Souza H, Borodin JO, Bardossy L, MacPherson DW, Blajchman MA. Prevention of transfusion-associated Chagas disease: efficacy of white cell-reduction filters in removing Trypanosome cruzi from infected blood. Transfusion 1995 35 : 723 6.
8. Cardo LJ, Asher L. Electron micrographic study of the removal of Trypanosoma cruzi from blood products by leukodepletion filters. Transfusion 2006 46 : 1067 8.
9. Cardo LJ, Salata J, Harman R, Mendez J, Weina PJ. Leukodepletion filters reduce Leishmania in blood products when used at collection or at the bedside. Transfusion 2006 46 : 897 902.
10. Cardo LJ, Asher L. Electron micrographic study of the removal of Leishmania from blood products by leukodepletion filters. Transfusion 2006 46 : 315 6.
11. Dzik W. Use of leukodepletion filters for the removal of bacteria. Immunol Invest 1995 24 : 95 115.
12. Weatherall DJ, Miller LH, Baruch DI, Marsh K, Doumbo OK, Casals-Pascual C, Roberts DJ. Malaria and the red cell. Hematol Am Soc Hematol Educ Program 2002 35 57.
13. Schuetz AN, Hillyer KL, Roback JD, Hillyer CD. Leukoreduction filtration of blood with sickle cell trait. Transfus Med Rev 2004 18 : 168 76.
14. Krailadsiri P, Gilcher R, Seghatchian J. Leukoreduction of sickle trait blood: an unresolved issue. Transfus Apher Sci 2001 24 : 223 5.
15. Byrne KM, Leitman SF, Schecter AN, Stroncek DF. Increasing oxygentension improves filtration of sickle trait donor blood. Br J Hematol 2003 122 : 678 81.
16. Katz LM. Transfusion-induced malaria in bacterial and parasitic contamination of blood components. Bethesda : American Association of Blood Banks 2003. p. 127 55.
17. Stuart MJ, Yamaja Setty BN. Hemostatic alterations in sickle cell disease: relationships to disease pathophysiology. Pediatr Pathol Mol Med 2001 20 : 27 46.
18. de Jong K, Larkin SK, Styles LA, Bookchin RM, Kupers FA. Characterization of the phosphatidylserine-exposing subpopulation of sickle cells. Blood 2001 98 : 860 7.
19. Yamaja Setty BN, Kulkarni S, Stuart MJ. Role of erythrocyte phosphatidylserine in sickle red cell-endothelial adhesion. Blood 2002 99 : 1564 71.
20. Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997 89 : 1121 32.
21. Borenstain-Ben YV, Barenholz Y, Hy-Am E, Rachmilewitz EA, Eldor A. Phosphatidylserine in the outer leaflet of red blood cells from beta-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. Am J Hematol 1993 44 : 63 5.
22. Kuypers FA, Yuan J, Lewis RA, Snyder LM, Kiefer CR, Bunyaratvej A, Fucharoen S, Ma L, Styles L, de Jong K, Schrier SL. Membrane phospholipid asymmetry in human thalassemia. Blood 1998 91 : 3044 51.
23. Hovav T, Goldfarb A, Artmann G, Yedgar S, Barshtein G. Enhanced adherence of β-thalassaemic erythrocytes to endothelial cells. Br J Haematol 1999 106 : 178 81.
24. Atichartakarn V, Angchaisukiri P, Aryurachai K, Onpun S, Chuncharunee S, Thakkinstian A, Atamasirikul K. Relationship between hypercoagulable state and erythrocyte phosphatidylserine exposure in splenectomized haemoglobin E/β-thalassaemic patients. Br J Haematol 2002 118 : 893 8.
25. Bonomini M, Sirolli V, Settefrati N, Dottori S, Di Liberato L, Arduini A. Increased erythrocyte phosphatidylserine exposure in chronic renal failure. J Am Soc Nephrol 1999 10 : 1982 90.
26. Wali RK, Jaffe S, Kumar D, Kalra RK. Alterations in organization of phospholipids in erythrocytes as factor in adherence to endothelial cells in diabetes mellitus. Diabetes 1988 37 : 104 11.
27. Wautier JL, Wautier MP. Erythrocytes and platelet adhesion to endothelium are mediated by specialized molecules. Clin Hemaorheol Microcirc 2004 30 : 181 4.
28. Schwartz RS, Olson JA, Raventos-Suarez C, Yee M, Heath RH, Lubin B, Nagel RL. Altered plasma membrane phospholipid organization in Plasmodium falciparum infected human erythrocytes. Blood 1987 69 : 401 7.
29. Cardo LJ, Hmel P, Wilder D. Stored packed red blood cells contain a procoagulant phospholipid reducible by leukodepletion filters and washing. Transfus Apher Sci 2008 38 : 141 7.
30. Cardo LJ, Wilder D, Salata J. Neutrophil priming, caused by cell membranes and microvesicles in packed red blood cell units, is abrogated by leukocyte depletion at collection. Transfus Apher Sci 2008 38 : 117 25.
31. Li Q, Gerena L, Xie L, Zhang J, Kyle D, Milhous W. Development and validation of flow cytometric measurement for parasitemia in cultures of Plasmodium falciparum vitally stained with YOYO-1. Cytometry A 2007 71A : 297 307.
32. Butthep P, Wanram S, Pattanapanyasat K, Vattanaviboon P, Fucharoen S, Wilairat P. Cytoadherence between endothelial cells and Plasmodium falciparum infected and noninfected normal and thalassemic red blood cells. Cytometry B Clin Cytom 2006 65B : 432 42.
33. Ho M, White NJ. Molecular mechanisms of cytoadherence in malaria [review]. Am J Physiol 1999 276 6 Pt 1 : C1231 42.
34. Schlegel RA, Prendergast TW, Williamson P. Membrane phospholipid asymmetry as a factor in erythrocyte endothelial cell interactions. J Cell Physiol 1985 123 : 215 8.
35. Cardigan R, Sutherland J, Garwood M, Krailadsiri P, Seghatchian J, Beard M, Beckman N, Williamson M. The effect of leukocyte depletion on the quality of fresh-frozen plasma. Br J Hematol 2001 114 : 233 40.
36. Pain A, Ferguson DJ, Kai O, Urban BC, Lowe B, Marsh K, Roberts DJ. Platelet-mediated clumping of Plasmodium falciparum-infected erythrocytes is a common adhesive phenotype and is associated with severe malaria. Proc Natl Acad Sci U S A 2001 98 : 1805 10.
37. Udomsangpetch R, Wahlin B, Carlson J, Berzins K, Torii M, Aikawa M, Perlmann P, Wahlgren M. Plasmodium falciparum infected erythrocytes form spontaneous erythrocyte rosettes. J Exp Med 1989 169 : 1835 40.
38. Rowe JA, Moulds JM, Newbold CI, Miller LH. Plasmodium falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature 1997 388 : 292 5.
39. Rowe JA, Handel IG, Thera MA, Deans AM, Lyke KE, Kone A, Diallo DA, Raza A, Kai O, Marsh K, Plowe CV, Doumbo OK, Moulds JM. Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced resetting. Proc Natl Acad Sci U S A 2007 104 : 17471 6.
40. Nash GB, O'Brien EO, Gordon-Smith EC, Dormandy JA. Abnormalities in the mechanical properties of red blood cells caused by Plasmodium falciparum. Blood 1989 74 : 855 61.
41. Mungai M, Tegtmeir G, Chamberland M, Parise M. Transfusion-transmitted malaria in the United States from 1963 through 1999. N Engl J Med 2001 344 : 1973 8.
42. Ohas EA, Adams JH, Waitumbi JN, Orago AS, Barbosa A, Lanar DE, Stoute JA. Measurement of antibody levels against region II of the erythrocyte-binding antigen 175 of Plasmodium falciparum in an area of malaria holoendemicity in western Kenya. Infect Immun 2004 72 : 735 41.
43. Kitchen AD, Chiodini PL. Malaria and blood transfusion. Vox Sang 2006 90 : 77 84.